Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis

Rheumatology International

Volumn 12, Issue 5, 1992, Pages 175-185

  Hofschneider, P H ^a   Winter, U ^a   Lemmel, E M ^b   Brolz B ^b   Gaus, W ^c   Schmid, S ^c   Obert, H J ^d   Stetter, C ^d   Auer, I O ^e   Papst, C ^e   Boesken, W H ^f   Stierle II, H E ^f   Botzenhardt, U ^g   Reemtsen, W ^g   Brackertz, D ^h   Richter, D ^h   Diehl, V ⁱ   von Kalle, A K ⁱ   Gartner C ^j   Herzig, S ^j   Goronzy, J ^k   Weyand, C ^k   Kalden, J R ^l   Strobel, F ^l   Machalke, K ^m   Peter, H H ⁿ   Meske, S ⁿ   Schattenkirchner, M ^o   Kruger K ^o   Sprekeler, R ^b   Waller, H D ^p   Saal, J G ^p   Warnatz, H ^q   Lemm, G ^q   Wilms, K ^e   Stolzenburg, T ^e   more..

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b Staatliches Rheumakrankenhaus Baden Baden ^*  (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d Bioferon biochemische Substanzen GmbH and Co ^*

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^g Rotes Kreuz Krankenhaus Bremen   (Germany)

^h St Vinzenz und Elizabeth Hospital   (Germany)

ⁱ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^j Krankenhaus Porz am Rhein   (Germany)

^k Medizinische Klinik und Poliklinik V   (Germany)

^l UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^m Klinik Lippe ^*  (Austria)

ⁿ UNIVERSITY OF FREIBURG   (Germany)

^o LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^p UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^q Department of Hematology/Oncology   (Germany)

more..

Author keywords

Controlled clinical trial; Interferon gamma; Multicenter; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; AGEUSIA; ARTHRALGIA; ARTICLE; BACKACHE; BLEEDING; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DYSPHAGIA; EPISTAXIS; EYE DISEASE; FEVER; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HALLUCINATION; HEADACHE; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MYALGIA; OTALGIA; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SKIN IRRITATION; SLEEP DISORDER; SUBCUTANEOUS DRUG ADMINISTRATION; TINNITUS; URINARY TRACT DISEASE; VERTIGO;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMAN; INTERFERON TYPE II; JOINTS; MALE; MIDDLE AGE; PAIN; TREATMENT OUTCOME;

EID: 0027093588     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/BF00302149     Document Type: Article

References (52)

1. Immunmodulierende Therapie der chronischen Polyarthritis mit Thymopentin. Eine multizentrische placebokontrollierte Studie an 119 Patienten
2. Lymphokines
3. The biology of interferon actions
4. The potential role of interferons and interferon antagonists in inflammatory disease
5. Immunomodulating effects of interferons: conclusions for therapy
6. Interferon gamma: ein janusköpfiger Mediator bei Entzündungen
7. Biology of interleukin-1
8. Biologic activities of interleukin-1 relevant to rheumatic diseases
9. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction
10. Prostaglandin-E2-, Interleukin-1-und Interferon-Gamma-Produktion mononukleärer Zellen von Patienten mit entzündlichen und degenerativen Gelenkerkrankungen
11. Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors
12. Interleukin-1 like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis
13. Synoviaspiegel von Interleukin-1 und C3a bei chronischer Polyarthritis, Psoriasisarthritis und aktivierter Arthrose
14. Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 und IL-1, and inhibition by IFN-alpha
15. Interleukin-1 release by rat synovial cells is dependent on sequential treatment with γ-interferon and lipopolysaccharide
16. The modulation of interleukin-1 production by interferon gamma, and the inhibitory effects of gold compounds
17. Regulation of interleukin-1 production by mouse peritoneal macrophages
18. Increased interleukin-1 levels from monocytes of rheumatoid arthritis patients during the early stages of the disease are down regulated in vitro by the addition of interferon-gamma
19. Spontaneous and LPS-stimulated production of intracellular IL-1β by synovial macrophages in rheumatoid arthritis is inhibited by IFN-γ
20. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-γ
21. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor
22. Comment on the articles by Firestein and Zvaifler
23. Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-γ
24. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon
25. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
26. Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma
27. Therapie der chronischen Polyarthritis. Ergebnisse einer Pilot-Studie mit Lymphokinen
28. Clinical trial with r-IFN-gamma in rheumatoid arthritis
29. Results of a multicenter placebocontrolled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma
30. Low-dose gamma interferon treatment of rheumatoid arthritis
31. Double-blind trial of recombinant interferon-gamma versus placebo in rheumatoid arthritis
32. Recombinant interferon gamma in rheumatoid arthritis. A double-blind study comparing Immuneron (recombinant interferon gamma) with placebo
33. Interferon gamma in der Therapie der chronischen Polyarthritis. Die Langzeitbehandlung in der Praxis
34. Therapie der rheumatoiden Arthritis mit rekombinantem Interferon-gamma. Klinischer Verlauf und Laborparameter während einjähriger Behandlung
35. Correlation of clinical and serological findings in patients with rheumatoid arthritis treated for one year with interferon-gamma
36. Prospective two-year followup of recombinant interferon-γ in rheumatoid arthritis
37. Behandlung der chronischen Polyarthritis mit Interferon-gamma. Ergebnisse einer Therapiestudie der Phase II bei 476 Patienten
38. Cloning and structure of the human immune interferon-gamma chromosomal gene
39. High-level expression of human interferon gamma in Escherichia coli under control of the PL promotor of bacteriophage lambda
40. Structure of the human immune interferon gene
41. 1958 revision of diagnostic criteria for rheumatoid arthritis
42. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
43. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
44. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis. Theoretic and clinical considerations
45. Methods for evaluating rheumatoid arthritis
46. Evaluation of a functional index in rheumatoid arthritis
47. Interferon bei chronischer Polyarthritis. Positive Wirkung in der klinischen Prüfung
48. Chronische Polyarthritis. Erste Ergebnisse mit Interferon-gamma
49. Interferon-gamma in der Therapie der chronischen Polyarthritis
50. Double-blind trial of recombinant γ-interferon versus placebo in the treatment of rheumatoid arthritis